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Palliative care for drug-resistant 
tuberculosis: An urgent call to action
To the Editor: The recent article entitled ‘Development of a hospital-
based model of palliative care in the Western Cape, South Africa’[1] 
recognised the important milestone South Africa (SA) has reached in 
adopting a policy on palliative care and begs the question of models 
of palliative care for drug-resistant (DR) tuberculosis (TB).
The mortality rates for multidrug-resistant (MDR)-TB and exten-
sively drug-resistant (XDR)-TB are 40% and 60%, respectively.[2] Of 
concern are a growing number of patients with programmatically 
incurable TB who remain smear- and culture-positive, giving rise 
to secondary cases. Currently there is no package of care available 
to these patients when treatment options have been exhausted. 
Therapeutic failure has become synonymous with additional failures 
from policy, programmatic, patient and social care perspectives.
The World Health Organization (WHO) issued the ‘Declaration on 
Palliative Care and MDR/XDR TB’,[3] which recognised palliative care 
as a human right and an essential component of managing patients 
with DR-TB, in November 2010. The World Health Assembly’s 
resolution in May 2014[4] mandated member states to strengthen and 
integrate palliative care into public health systems. In March 2014, 
the WHO adopted the End TB Strategy with the vision of ‘A world 
free of tuberculosis – zero deaths, disease and suffering’, emphasising 
patient-centred care.[5]
In 2015, the SA National Department of Health commissioned a 
WHO-led evaluation of the DR-TB programme on the implementa-
tion of decentralisation and deinstitutionalised management of 
MDR-TB. The report estimates that 90% of patients who experience 
treatment failure will receive home-based care and only 10 - 15% of 
patients will require specialised long-term stay facilities.[6]
Palliative care is an essential component of universal health 
coverage, requiring a scalable, integrated response into DR-TB care. 
It must include infection control measures to mitigate transmission, 
symptom assessment and management, including access to opioids, 
to improve the quality of life of patients, while supporting their 
families. Patients with DR-TB experience a myriad of distressing 
symptoms including total pain, nausea, cachexia, dyspnoea and 
haemotypsis, adding to the emotional angst of confronting their 
mortality. Effective implementation can reduce suffering and 
potentially decrease community transmission with infection control, 
screening of contacts and retention in care.
While the search for better drugs, vaccines and diagnostic tests 
must be intensified, palliative care for patients with DR-TB must 
be provided now! This can be achieved with political leadership 
and allocation of resources including palliative care training for 
health workers. SA, a signatory to the World Health Assembly 
resolution, must champion the inclusion of palliative care for patients 
with DR-TB at the first United Nations High Level Meeting on 
Tuberculosis to be held on 26 September 2018 in New York with the 
theme ‘United to end tuberculosis: An urgent global response to a 
global epidemic’.
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